Alkem Laboratories Limited (BOM:539523)
India · Delayed Price · Currency is INR 5,497.80
+45.55 (0.84%)
At close: May 29, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 657.37 billion as of June 1, 2026. Its market cap has increased by 11.15% in one year.
Market Cap
657.37B
Enterprise Value
633.20B
Revenue
147.12B
Ranking
n/a
PE Ratio
28.56
Stock Price
5,497.80
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 657.37B, an increase of 297.92%. That is a compound annual growth rate of 14.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 657.37B | -0.15% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.49T |
| Dr. Reddy's Laboratories | 1.08T |
| Lupin | 1.04T |
| Abbott India | 571.12B |
| GlaxoSmithKline Pharmaceuticals | 374.17B |
| J. B. Chemicals & Pharmaceuticals | 348.81B |
| AstraZeneca Pharma India | 216.79B |
| Granules India | 191.37B |